Adjuvant and neoadjuvant therapy for gastric cancer

Surgical Clinics of North America

Volumn 85, Issue 5, 2005, Pages 1033-1051

  Gonzalez, Ricardo J ^a   Mansfield, Paul F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; LOMUSTINE; METHOTREXATE; MITOMYCIN C; PICIBANIL; TEGAFUR; UFT; VINCRISTINE;

ABDOMINAL PAIN; ADVANCED CANCER; ANEMIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DYSPHAGIA; GASTROINTESTINAL HEMORRHAGE; HUMAN; MULTIPLE ORGAN FAILURE; NAUSEA AND VOMITING; OVARY METASTASIS; PERITONEUM METASTASIS; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH SURGERY; WEIGHT REDUCTION;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; GASTRECTOMY; HUMANS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS;

EID: 24044520336     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2005.05.004     Document Type: Review

References (75)

1. W. Haenszel Variation in incidence of and mortality from stomach cancer, with particular reference to the United States J Natl Cancer Inst 21 1958 213 262
2. Surveillance, Epidemiology, and End Results (SEER) program, public use data (1975-2001). Available at: http://seer.cancer.gov/faststats/. Accessed June 28, 2005.
3. C.L. Wiggins, T.M. Becker, and C.R. Key Stomach cancer among New Mexico's American Indians, Hispanic whites, and non-Hispanic whites Cancer Res 49 1989 1595 1599
4. P. Pisani, D.M. Parkin, and F. Bray Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 1999 18 29
5. D.M. Parkin, P. Pisani, and J. Ferlay Global cancer statistics CA Cancer J Clin 49 1999 33 64
6. Y. Esaki, R. Hirayama, and K. Hirokawa A comparison of patterns of metastasis in gastric cancer by histologic type and age Cancer 65 1990 2086 2090
7. Y. Maehara, S. Moriguchi, and Y. Kakeji Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis Surgery 110 1991 820 823
8. J.C. Yao, I.I. Schnirer, and S. Reddy Effects of sex and racial/ethnic group on the pattern of gastric cancer localization Gastric Cancer 5 2002 208 212
9. S.A. Hundahl, J.L. Phillips, and H.R. Menck The National Cancer Data Base report on poor survival of US gastric carcinoma patients treated with gastrectomy: 5th edition. American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis Cancer 88 2000 921 932
10. J.S. Macdonald, S. Smalley, and J. Benedetti Chemotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 2001 725 730
11. J.C. Yao, K. Shimada, and J.A. Ajani Adjuvant therapy for gastric carcinoma: closing out the century Oncology (Huntingt) 13 1999 1485 1494 [discussion: 1497-502]
12. C.C. Earle, and J.A. Maroun Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials Eur J Cancer 35 1999 1059 1064
13. K.G. Janunger, L. Hafstrom, and P. Nygren A systematic overview of chemotherapy effects in gastric cancer Acta Oncol 40 2001 309 326
14. H. Imanaga, and H. Nakazato Results of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence World J Surg 2 1977 213 221
15. J.J. Grau, J. Estape, and F. Alcobendas Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients Eur J Cancer 29A 1993 340 342
16. Gastrointestinal Tumor Study Group A comparison of combination chemotherapy and combined modality therapy for locally advanced gastric carcinoma Cancer 49 1982 1116 1122
17. G.A. Higgins, J.H. Amadeo, and D.E. Smith Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology Group report Cancer 52 1983 1105 1112
18. P.F. Engstrom, P.T. Lavin, and H.O. Douglass Jr. Postoperative adjuvant 5-fluorouracil plus mehyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275) Cancer 55 1985 1868 1873
19. J.S. Macdonald, T.R. Fleming, and R.F. Peterson Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: a Southwest Oncology Group study Ann Surg Oncol 2 1995 488 494
20. M. Lise, D. Nitti, and A. Marchet Final results of a Phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer J Clin Oncol 13 1995 2757 2763
21. R.C. Coombes, P.S. Schein, and C.E. Chilvers A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group J Clin Oncol 8 1990 1362 1369
22. M.T. Hallissey, J.A. Dunn, and L.C. Ward The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up Lancet 343 1994 1309 1312
23. J.E. Krook, M.J. O'Connell, and H.S. Wieand A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer Cancer 67 1991 2454 2458
24. B. Neri, V. de Leonardis, and S. Romano Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study Br J Cancer 73 1996 549 552
25. W.H. Allum, M.T. Hallissey, and K.A. Kelly Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial Lancet 1 1989 571 574
26. J.J. Grau, J. Estape, and J. Fuster Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer J Clin Oncol 16 1998 1036 1039
27. Carrato A, Diaz-Rubio E, Medrano J, et al. Phase III trial of surgery versus adjuvant chemotherapy with mitomycin C (MMC) and tegafur plus uracil (UFT), starting within the first week after surgery, for gastric adenocarcinoma [abstract]. In: Proceedings of the Annual Meeting of the American Society for Clininical Oncolology; 1995. p. A468.
28. The Italian Gastrointestinal Tumor Study Group Adjuvant treatments following curative resection for gastric cancer Br J Surg 75 1988 1100 1104
29. R. Jakesz, C. Dittrich, and J. Funovics The effect of adjuvant chemotherapy in gastric carcinoma is dependent on tumor histology: 5-year results of a prospective randomized trial Recent Results Cancer Res 110 1988 44 51
30. J.P. Kim, O.J. Kwon, and S.T. Oh Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer Ann Surg 216 1992 269 278 [discussion: 278-9]
31. T. Nakajima, A. Nashimoto, and M. Kitamura Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomized trial Lancet 354 1999 273 277
32. G.A. Higgins Jr., J.H. Amadeo, and J. McElhinney Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report Cancer 53 1984 1 8
33. R. Schiessel, J. Funovics, and B. Schick Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: results of a randomized trial Acta Med Austriaca 6 1989 68 69
34. T. Sautner, F. Hofbauer, and D. Depisch Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer J Clin Oncol 12 1994 970 974
35. A. Hagiwara, T. Takahashi, and O. Kojima Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer Lancet 339 1992 629 631
36. H.R. Rosen, G. Jatzko, and S. Repse Adjuvant intraperitoneal chemotherapy with carbon-adsorbed mitomycin in patients with gastric cancer: results of a randomized multicenter trial of the Austrian Working Group for Surgical Oncology J Clin Oncol 16 1998 2733 2738
37. W. Yu, I. Whang, and H. Chung Indications for early postoperative intraperitioneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial World J Surg 25 2001 985 990
38. R. Hamazoe, M. Maeta, and N. Kaibara Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study Cancer 73 1994 2048 2052
39. M. Ikeguchi, A. Kondou, and A. Oka Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion Eur J Surg 161 1995 581 586
40. T. Fujimura, Y. Yonemura, and K. Muraoka Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study World J Surg 18 1994 150 155
41. Y. Yonemura, T. Fujimura, and S. Fushida Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination World J Surg 15 1991 530 535 [discussion: 535-6]
42. Y. Yonemura, X. de Aretxabala, and T. Fujimura Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled trial Hepatogastroenterology 48 2001 1776 1782
43. C.G. Moertel, D.S. Childs Jr., and R.J. Reitemeier Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer Lancet 2 1969 865 867
44. E. Robinson, and Y. Cohen The combination of surgery, radiotherapy, and chemotherapy in the treatment of gastric cancer Recent Results Cancer Res 1977 177 180
45. W.F. Regine, and M. Mohiuddin Impact of adjuvant therapy on locally advanced adenocarcinoma of the stomach Int J Radiat Oncol Biol Phys 24 1992 921 927
46. A. Slot, J.H. Meerwaldt, and W.L. van Putten Adjuvant postoperative radiotherapy for gastric carcinoma with poor prognostic signs Radiother Oncol 16 1989 269 274
47. R. Martinez-Monge, F.A. Calvo, and I. Azinovic Patterns of failure and long-term results in high-risk resected gastric cancer treated with postoperative radiotherapy with or without intraoperative electron boost J Surg Oncol 66 1997 24 29
48. E. Gez, A. Sulkes, and T. Yablonsky-Peretz Combined 5-fluorouracil (5-FU) and radiation therapy following resection of locally advanced gastric carcinoma J Surg Oncol 31 1986 139 142
49. M.A. Poon, M.J. O'Connell, and C.G. Moertel Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life of patients with advanced colorectal carcinoma J Clin Oncol 7 1989 1407 1418
50. A.M. Lowy, P.F. Mansfield, and S.D. Leach Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer Ann Surg 229 1999 303 308
51. H. Wilke, P. Presser, and U. Fink Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a Phase II study of etoposide, doxorubicin and cisplatin J Clin Oncol 7 1989 1318 1326
52. J.A. Ajani, D.M. Ota, and J.M. Jessup Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy Cancer 68 1991 1501 1506
53. J.A. Ajani, R.J. Mayer, and D.M. Ota Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma J Natl Cancer Inst 85 1993 1839 1844
54. U. Fink, C. Schuhmacher, and H.J. Stein Preoperative chemotherapy for Stage III-IV gastric carcinoma: feasibility, response and outcome after complete resection Br J Surg 82 1995 1248 1252
55. P. Rougier, M. Mahjoubi, and P. Lasser Neoadjuvant chemotherapy in locally advanced gastric carcinoma - a Phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum Eur J Cancer 30A 1994 1269 1275
56. D. Kelsen, M. Karpeh, and G. Schwartz Neoadjuvant therapy of high-risk gastric cancer: a Phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil J Clin Oncol 14 1996 1818 1828
57. Y. Yonemura, T. Sawa, and K. Kinoshita Neoadjuvant chemotherapy for high-grade advanced gastric cancer World J Surg 17 1993 256 261
58. J.A. Ajani, P.F. Mansfield, and P.M. Lynch Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma J Clin Oncol 17 1999 2403 2411
59. C. Barone, A. Cassano, and C. Pozzo Long term follow up of a pilot Phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer Oncology 67 2004 48 53
60. P. Crookes, C.G. Leichman, and L. Leichman Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report Cancer 79 1997 1767 1775
61. S. Cascinu, M. Scartozzi, and R. Labianca High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) Br J Cancer 90 2004 1521 1525
62. H.H. Hartgrink, C.J. van de Velde, and H. Putter Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial Eur J Surg Oncol 30 2004 643 649
63. K. Ott, A. Sendler, and K. Becker Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin in locally advanced gastric cancer: a prospective Phase II study Gastric Cancer 6 2003 159 167
64. I. Songun, H.J. Kaizer, and J. Hermans Chemotherapy for operable gastric cancer: results of the Dutch randomized FAMTX trial. The Dutch Gastric Cancer Study Group Eur J Cancer 35 1999 558 562
65. J.R. Siewart, C. Schumacher, and U. Fink The German EORTC study of neoadjuvant therapy of stomach carcinoma Langenbecks Arch Chir Suppl Kongressbd 115 1998 717 719
66. W. Allum, D. Cunningham, and S. Weeden Perioperative chemotherapy in operable gastric and lower oesophageal cancer: a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971) [abstract] Proc Am Soc Clin Oncol 22 249 2003
67. Z.X. Zhang, X.Z. Gu, and W.B. Yin Randomized clinical trial of the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of the gastric cardia (AGC) - report on 370 patients Int J Radiat Oncol Biol Phys 42 1998 929 934
68. L.K. Groves, and A. Rodriguez-Antunez Treatment of carcinoma of the esophagus and gastric cardia with concentrated preoperative irradiation followed by early operation. A progress report Ann Thorac Surg 5 1973 333 338
69. S. Kamimura, S. Mikuriya, and O. Hara [Preoperative radiotherapy of carcinoma of the stomach and breast] Gan to Kagaku Ryoho 14 1987 1558 1563 [in Japanese]
70. S. Mikuriya, and H. Oh'ami Radiotherapy and cellular infiltration of tumor nests Radiat Med 1 1983 248 254
71. W. Yu, I. Whang, and A. Averbach Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer Am Surg 64 1998 1104 1108
72. I.B. Shchepotin, S.R. Evans, and V. Chorny Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma Surg Oncol 3 1994 37 44
73. A comparison of combination chemotherapy and combination therapy for locally advanced gastric carcinoma. Gastrointestinal Tumor Study Group Cancer 49 1982 1771 1777
74. A.M. Lowy, B.W. Feig, and N. Janjan A pilot study of preoperative chemoradiotherapy for resectable gastric cancer Ann Surg Oncol 8 2001 519 524
75. J.A. Ajani, P.F. Mansfield, and N. Janjan Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric cancer J Clin Oncol 22 2004 2774 2780